Julia Kennedy
Hematology & Oncology · Philadelphia, PANPI 1992810311
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,222 and has fallen 98.6% since, to $17 in 2023. That places this record below the midpoint for hematology & oncology clinicians in PA, where the typical reported total is $1,277.
Across 88 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$276
- Novartis$157
- Bristol Myers Squibb$117
- Tesaro, Inc.$105
- Eisai Inc.$104
- Puma Biotechnology, Inc.$96
- plus $761 from 22 others
What the payments were for
- Food & beverage$1,60399%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 9 | $276 |
| Novartis | 9 | $157 |
| Bristol Myers Squibb | 6 | $117 |
| Tesaro, Inc. | 6 | $105 |
| Eisai Inc. | 5 | $104 |
| Puma Biotechnology, Inc. | 6 | $96 |
| Amgen | 4 | $73 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $69 |
| Seagen Inc. | 4 | $68 |
| Lilly USA, LLC | 4 | $61 |
| Sanofi | 4 | $61 |
| Foundation Medicine, Inc. | 4 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| AstraZeneca | 3 | $49 |
| Astellas Pharma US Inc | 3 | $48 |
| Bayer | 2 | $37 |
| Boston Scientific | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| Merck | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| EMD Serono, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Pfizer | 1 | $15 |
| Acceleron Pharma, Inc. | 1 | $14 |
| Taiho Oncology, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Clovis Oncology, Inc. | 1 | $1 |
How this compares
$1,616 in reported general payments places this provider in the 50th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Philadelphia
- Henry FungPhiladelphia$730K
- Charu AggarwalPhiladelphia$541K
- Corey LangerPhiladelphia$492K
- Ankur ParikhPhiladelphia$329K
- Catherine LaiPhiladelphia$281K
- Stephen SchusterPhiladelphia$218K
- Keith PratzPhiladelphia$173K
- David PorterPhiladelphia$140K
- Adam BinderPhiladelphia$136K
- Marcela MausPhiladelphia$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.